Precision Promise (PrP): An adaptive, multi-arm registration trial in metastatic pancreatic ductal adenocarcinoma (PDAC).

Authors

null

Vincent J. Picozzi

Virginia Mason Hospital and Medical Center, Seattle, WA

Vincent J. Picozzi , Anne-Marie Duliege , Eric Andrew Collisson , Anirban Maitra , Manuel Hidalgo , Andrew Eugene Hendifar , Gregory Lawrence Beatty , Sudheer Doss , Lynn McCormick Matrisian , Pamela S Herena , Julie Fleshman , Michelle A. Detry , Donald A. Berry , Diane M. Simeone

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT04229004

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS4188)

DOI

10.1200/JCO.2022.40.16_suppl.TPS4188

Abstract #

TPS4188

Poster Bd #

159a

Abstract Disclosures

Similar Posters

First Author: Andrew L. Coveler

First Author: Ravi Kumar Paluri

Poster

2021 Gastrointestinal Cancers Symposium

Real-world outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma.

Real-world outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma.

First Author: Laura Miotke